In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Erythra-Derm Drug Master File in Korea (Erythra-Derm KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Erythra-Derm. The MFDS reviews the Erythra-Derm KDMF as part of the drug registration process and uses the information provided in the Erythra-Derm KDMF to evaluate the safety and efficacy of the drug.
After submitting a Erythra-Derm KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Erythra-Derm API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Erythra-Derm suppliers with KDMF on PharmaCompass.